These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34586637)
21. Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients. Mansi M; Zanichelli A; Coerezza A; Suffritti C; Wu MA; Vacchini R; Stieber C; Cichon S; Cicardi M J Intern Med; 2015 May; 277(5):585-93. PubMed ID: 25196353 [TBL] [Abstract][Full Text] [Related]
22. A follow-up survey of patients with acquired angioedema due to C1-inhibitor deficiency. Pólai Z; Balla Z; Andrási N; Kőhalmi KV; Temesszentandrási G; Benedek S; Varga L; Farkas H J Intern Med; 2021 Apr; 289(4):547-558. PubMed ID: 33215769 [TBL] [Abstract][Full Text] [Related]
23. Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study. Zanichelli A; Bova M; Coerezza A; Petraroli A; Triggiani M; Cicardi M Allergy; 2012 Aug; 67(8):1074-7. PubMed ID: 22686628 [TBL] [Abstract][Full Text] [Related]
24. Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema. Farkas H; Reshef A; Aberer W; Caballero T; McCarthy L; Hao J; Nothaft W; Schranz J; Bernstein JA; Li HH J Allergy Clin Immunol Pract; 2017; 5(6):1671-1678.e2. PubMed ID: 28601641 [TBL] [Abstract][Full Text] [Related]
25. Longitudinal experience with treatment of acquired angioedema using tranexamic acid. Kesh S; Singh U; Bernstein JA Allergy Asthma Proc; 2022 Sep; 43(5):413-418. PubMed ID: 36065111 [No Abstract] [Full Text] [Related]
26. Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: clinical and molecular characterization. Sbattella M; Zanichelli A; Ghia P; Gattei V; Suffritti C; Teatini T; Cicardi M; Castelli R Med Oncol; 2018 Aug; 35(9):118. PubMed ID: 30073422 [TBL] [Abstract][Full Text] [Related]
27. Serum complexes between C1INH and C1INH autoantibodies for the diagnosis of acquired angioedema. López-Lera A; Garrido S; Nozal P; Skatum L; Bygum A; Caballero T; López Trascasa M Clin Exp Immunol; 2019 Dec; 198(3):341-350. PubMed ID: 31397881 [TBL] [Abstract][Full Text] [Related]
28. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant. Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O; Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922 [TBL] [Abstract][Full Text] [Related]
29. Genetic test indications and interpretations in patients with hereditary angioedema. Weiler CR; van Dellen RG Mayo Clin Proc; 2006 Jul; 81(7):958-72. PubMed ID: 16835976 [TBL] [Abstract][Full Text] [Related]
30. Long term follow-up of complement parameters to improve the management of acquired angioedema due to C1-inhibitor deficiency. Polai Z; Balla Z; Varga L; Benedek S; Farkas H Heliyon; 2022 Nov; 8(11):e11292. PubMed ID: 36387475 [TBL] [Abstract][Full Text] [Related]
31. Nanofiltrated C1-esterase-inhibitor in the prophylactic treatment of bradykinin-mediated angioedema. Greve J; Hahn J; Nordmann M; Schuler PJ; Bas M; Hoffmann TK; Hajdu Z; Buchberger M; Strassen U Transfusion; 2016 May; 56(5):1022-9. PubMed ID: 26756974 [TBL] [Abstract][Full Text] [Related]